Skip to main content
menu
Trial Innovation Network: Learning and Growing

Trial Innovation Network: Learning and Growing

After its first round of proposal review, the Trial Innovation Network has approved 21 proposals and has made some changes to the proposal submission process. URMC faculty can submit proposals to receive services or consultations on their clinical trials through the network. Pending the results of consultations, clinical trials may eventually be fully implemented through the network.

CTSI Offers New Matchmaking Service: the Research Teambuilder

CTSI Offers New Matchmaking Service: the Research Teambuilder

The CTSI is offering a new Matchmaking service, which can connect faculty members with established researchers who have obtained funding in their field. Your personalized Matchmaker report created by the CTSI is broken in to two sections: a funding climate report at the top and then a ranked listing of the top six research projects that most closely match the supplied text at the bottom. This information can be used to forge new research collaborations; recruit new faculty members; identify mentors for junior faculty members and students; and help faculty better understand the types of research projects that are already underway.

Announcing the Results of the 2017 America’s Got Regulatory Science Talent Competition

Announcing the Results of the 2017 America’s Got Regulatory Science Talent Competition

Congratulations to the top three finishers of the Fourth Annual “America’s Got Regulatory Science Talent” competition, in which students present novel ideas on how to solve regulatory science issues in nine scientific priority areas outlined by the FDA. 

Scott Steele selected to serve on FDA’s Science Board

Scott Steele selected to serve on FDA’s Science Board

Scott Steele, Ph.D., was recently tapped for a seat on the Food and Drug Administration’s Science Board, which guides the FDA on complex scientific and technical issues. 

CTSI Fostered Development of Drug that Extends Effectiveness of HIV Therapy

CTSI Fostered Development of Drug that Extends Effectiveness of HIV Therapy

2011 CTSI Incubator awardees have made new discoveries stemming from their Incubator project. A drug originally tested for its ability to treat HIV associated dementia, also surprisingly prolongs the effectiveness of HIV drugs and helps cells get rid of cellular “trash”, like viruses.